Not applicableAvailableNCT07000695What this trial is testingManaged Access Programs for TQJ230, PelacarsenWho this might be right forAtherosclerotic Cardiovascular Disease, ASCVD Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT07487363What this trial is testingTB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVDWho this might be right forAtherosclerotic Cardiovascular DiseasesEndothelial Dysfunction Hudson Biotech 80
Early research (Phase 1)Looking for participantsNCT07428473What this trial is testingSTX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)Who this might be right forElevated LDL-C and High Cholesterol Monash University 64
Not applicableEnded earlyNCT04197453What this trial is testingThe Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)Who this might be right forASCVD Amgen 752
Not applicableUnknownNCT03606824What this trial is testingThyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)Who this might be right forDyslipidemiaSubclinical hypothyroïdismStatin+1 more Shaochun.Li 248
Not applicableUnknownNCT05148182What this trial is testingMetabolomics Characterization of Biomarkers of ASCVD and Prediction ModelWho this might be right forAtherosclerosisPrediction Model Shanghai 10th People's Hospital 1,869
Not applicableStudy completedNCT05362903What this trial is testingA Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world SettingWho this might be right forHypercholesterolemia Novartis Pharmaceuticals 1,868
Not applicableNot Yet RecruitingNCT07615296What this trial is testingTarget-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness AssessmentWho this might be right forAtherosclerotic Cardiovascular Disease (ASCVD) Beijing Anzhen Hospital 6,000
Testing effectiveness (Phase 2)Study completedNCT04992065What this trial is testingA Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart DiseaseWho this might be right forAtherosclerotic Cardiovascular Disease Novo Nordisk A/S 267
Not applicableStudy completedNCT06507852What this trial is testingA Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial HypercholesterolemiaWho this might be right forAtherosclerotic Cardiovascular DiseaseHypercholesterolemia Novartis 95
Large-scale testing (Phase 3)Study completedNCT02991118What this trial is testingEvaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular RiskWho this might be right forHypercholesterolemiaAtherosclerotic Cardiovascular Disease Esperion Therapeutics, Inc. 779
Not applicableNot Yet RecruitingNCT07208331What this trial is testingEvaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk ManagementWho this might be right forAtherosclerotic Cardiovascular Disease (ASCVD)HypertensionDyslipidemia Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 750
Large-scale testing (Phase 3)Study completedNCT05142722What this trial is testingRandomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying TherapiesWho this might be right forDyslipidemiasHigh CholesterolHypercholesterolemia+2 more NewAmsterdam Pharma 2,530
Not applicableStudy completedNCT07615179What this trial is testingAlirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD)Who this might be right forAtherosclerotic Cardiovascular Disease Without Prior Ischemic Events Sanofi 4,545
Not applicableStudy completedNCT05858879What this trial is testingNotification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)Who this might be right forASCVDCoronary Artery Calcification Stanford University 233
Large-scale testing (Phase 3)Study completedNCT02666664What this trial is testingEvaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)Who this might be right forHypercholesterolemiaAtherosclerotic Cardiovascular Diseases Esperion Therapeutics, Inc. 2,230
Large-scale testing (Phase 3)Study completedNCT06267560What this trial is testingLp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVDWho this might be right forElevated Lp(a) and Established Atherosclerotic Cardiovascular Disease Novartis Pharmaceuticals 422
Not applicableActive Not RecruitingNCT05726838What this trial is testingThe Belgian REAL (BE.REAL) RegistryWho this might be right forAtherosclerotic Cardiovascular Disease Novartis Pharmaceuticals 600
Post-approval studies (Phase 4)Enrolling By InvitationNCT05579626What this trial is testingComparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)Who this might be right forPre DiabetesASCVD Seung-Whan Lee, M.D., Ph.D. 4,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05581303What this trial is testingOlpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes TrialWho this might be right forAtherosclerotic Cardiovascular Disease Amgen 7,297